LYRA- Lyra Therapeutics, Inc.

Name: Lyra Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Lyra Therapeutics, Inc. (LYRA) has 7 insiders with recent SEC Form 4 filings, including 14 buys and 4 sells. LYRA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Palasis Maria	1.10M	$800.6K	-
CFO	Cavalier Jason	518.5K	$378.5K	-
Dir	Merrifield C Ann	32.0K	$23.4K	-
Dir	Tobin James R	32.0K	$23.4K	-
Dir	Snyderman Nancy Lynn Md	32.0K	$23.4K	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 10, 2022	Merrifield C Ann	Director	Buy	4,000	$5.05	$20,200.00	+54.6%	+24.4%	-42.0%
May 16, 2022	Merrifield C Ann	Director	Buy	3,828	$4.83	$18,485.50	+36.5%	+23.9%	-45.6%
Apr 12, 2022	Nbvm Gp, LLC	10% Owner	Buy	2,369,667	$4.22	$9,999,994.74	+138.3%	-1.8%	-59.5%
Apr 12, 2022	Anderson Edward T	Director, 10% Owner	Buy	2,488,150	$4.22	$10,499,993.00	+145.2%	-1.8%	-59.5%
Apr 12, 2022	Perceptive Advisors LLC51	Director, 10% Owner	Buy	5,924,170	$4.22	$24,999,997.40	+306.3%	-1.8%	-59.5%
Apr 12, 2022	Waksal Harlan	Executive Chair	Buy	236,966	$4.22	$999,996.52	New	-1.8%	-59.5%
Jun 17, 2021	Merrifield C Ann	Director	Buy	3,500	$8.97	$31,394.65	New	-8.5%	-44.9%
Dec 16, 2020	Snyderman Nancy Lynn Md	Director	Buy	1,025	$9.72	$9,963.00	New	-	-
May 5, 2020	Nbvm Gp, LLC	10% Owner	Sell	24,183	$16.00	$386,928.00	-1.6%	-	-
May 5, 2020	Soleus Private Equity GP I, LLC	10% Owner	Sell	16,909	$16.00	$270,544.00	-3.6%	-	-

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC